These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35705775)

  • 81. Perihilar cholangiocarcinoma: What the radiologist needs to know.
    Tzedakis S; Sindayigaya R; Dhote A; Marchese U; Barret M; Belle A; Coriat R; Barat M; Soyer P; Fuks D
    Diagn Interv Imaging; 2022 Jun; 103(6):288-301. PubMed ID: 35314126
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A Multi-institutional International Analysis of Textbook Outcomes Among Patients Undergoing Curative-Intent Resection of Intrahepatic Cholangiocarcinoma.
    Merath K; Chen Q; Bagante F; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Weiss MJ; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Cloyd JM; Pawlik TM
    JAMA Surg; 2019 Jun; 154(6):e190571. PubMed ID: 31017645
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Surgical treatment of perihilar cholangiocarcinoma in octogenarians: a single center experience.
    Takahashi Y; Ebata T; Yokoyama Y; Igami T; Sugawara G; Nagino M
    J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):324-31. PubMed ID: 22706427
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Factors associated with failure to rescue after major hepatectomy for perihilar cholangiocarcinoma: A 15-year single-center experience.
    Benzing C; Schmelzle M; Atik CF; Krenzien F; Mieg A; Haiden LM; Wolfsberger A; Schöning W; Fehrenbach U; Pratschke J
    Surgery; 2022 Apr; 171(4):859-866. PubMed ID: 35123795
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Early postoperative decrease of skeletal muscle mass predicts recurrence and poor survival after surgical resection for perihilar cholangiocarcinoma.
    Yasuta S; Sugimoto M; Kudo M; Kobayashi S; Takahashi S; Konishi M; Gotohda N
    BMC Cancer; 2022 Dec; 22(1):1358. PubMed ID: 36578076
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Postoperative Liver Failure Risk Score: Identifying Patients with Resectable Perihilar Cholangiocarcinoma Who Can Benefit from Portal Vein Embolization.
    Olthof PB; Wiggers JK; Groot Koerkamp B; Coelen RJ; Allen PJ; Besselink MG; Busch OR; D'Angelica MI; DeMatteo RP; Kingham TP; van Lienden KP; Jarnagin WR; van Gulik TM
    J Am Coll Surg; 2017 Sep; 225(3):387-394. PubMed ID: 28687509
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma.
    Abbas S; Sandroussi C
    HPB (Oxford); 2013 Jul; 15(7):492-503. PubMed ID: 23750491
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Perihilar cholangiocarcinoma (Klatskin tumor)].
    Stavrou GA; Donati M; Faiss S; Jenner RM; Niehaus KJ; Oldhafer KJ
    Chirurg; 2014 Feb; 85(2):155-65; quiz 166-7. PubMed ID: 24464335
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients.
    Rea DJ; Munoz-Juarez M; Farnell MB; Donohue JH; Que FG; Crownhart B; Larson D; Nagorney DM
    Arch Surg; 2004 May; 139(5):514-23; discussion 523-5. PubMed ID: 15136352
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A Study on Radial Margin Status in Resected Perihilar Cholangiocarcinoma.
    Shinohara K; Ebata T; Shimoyama Y; Mizuno T; Yokoyama Y; Yamaguchi J; Onoe S; Watanabe N; Nagino M
    Ann Surg; 2021 Mar; 273(3):572-578. PubMed ID: 30946074
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Surgical resection for hilar cholangiocarcinoma: experience improves resectability.
    Cannon RM; Brock G; Buell JF
    HPB (Oxford); 2012 Feb; 14(2):142-9. PubMed ID: 22221577
    [TBL] [Abstract][Full Text] [Related]  

  • 92. High tumor budding is a strong predictor of poor prognosis in the resected perihilar cholangiocarcinoma patients regardless of neoadjuvant therapy, showing survival similar to those without resection.
    Ito T; Kuriyama N; Kozuka Y; Komatsubara H; Ichikawa K; Noguchi D; Hayasaki A; Fujii T; Iizawa Y; Kato H; Tanemura A; Murata Y; Kishiwada M; Mizuno S; Usui M; Sakurai H; Isaji S
    BMC Cancer; 2020 Mar; 20(1):209. PubMed ID: 32164621
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Comparison between liver transplantation and resection for hilar cholangiocarcinoma: A systematic review and meta-analysis.
    Moris D; Kostakis ID; Machairas N; Prodromidou A; Tsilimigras DI; Ravindra KV; Sudan DL; Knechtle SJ; Barbas AS
    PLoS One; 2019; 14(7):e0220527. PubMed ID: 31365594
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor).
    Dinant S; Gerhards MF; Rauws EA; Busch OR; Gouma DJ; van Gulik TM
    Ann Surg Oncol; 2006 Jun; 13(6):872-80. PubMed ID: 16614876
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The Long-Term Outcome of Laparoscopic Resection for Perihilar Cholangiocarcinoma Compared with the Open Approach: A Real-World Multicentric Analysis.
    Qin T; Wang M; Zhang H; Li J; Deng X; Zhang Y; Zhao W; Fan Y; Li D; Chen X; Feng Y; Zhu S; Xing Z; Yu G; Xu J; Xie J; Dou C; Ma H; Liu G; Shao Y; Chen W; Xu S; Liu J; Liu J; Yin X; Qin R;
    Ann Surg Oncol; 2023 Mar; 30(3):1366-1378. PubMed ID: 36273058
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Defining and predicting textbook outcomes for perihilar cholangiocarcinoma: analysis of factors improving achievement of desired postoperative outcomes.
    Clocchiatti L; Marino R; Ratti F; Pedica F; Casadei Gardini A; Lorenzin D; Aldrighetti L
    Int J Surg; 2024 Jan; 110(1):209-218. PubMed ID: 37800550
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effect of vascular resection for perihilar cholangiocarcinoma: a systematic review and meta-analysis.
    Liu Y; Li G; Lu Z; Wang T; Yang Y; Wang X; Liu J
    PeerJ; 2021; 9():e12184. PubMed ID: 34631316
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Current Advances in Minimally Invasive Surgical Management of Perihilar Cholangiocarcinoma.
    Rahnemai-Azar AA; Abbasi A; Tsilimigras DI; Weber SM; Pawlik TM
    J Gastrointest Surg; 2020 Sep; 24(9):2143-2149. PubMed ID: 32410178
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Liver Transplantation as a New Standard of Care in Patients With Perihilar Cholangiocarcinoma? Results From an International Benchmark Study.
    Breuer E; Mueller M; Doyle MB; Yang L; Darwish Murad S; Anwar IJ; Merani S; Limkemann A; Jeddou H; Kim SC; López-López V; Nassar A; Hoogwater FJH; Vibert E; De Oliveira ML; Cherqui D; Porte RJ; Magliocca JF; Fischer L; Fondevila C; Zieniewicz K; Ramírez P; Foley DP; Boudjema K; Schenk AD; Langnas AN; Knechtle S; Polak WG; Taner CB; Chapman WC; Rosen CB; Gores GJ; Dutkowski P; Heimbach JK; Clavien PA
    Ann Surg; 2022 Nov; 276(5):846-853. PubMed ID: 35894433
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Efficacy and safety of irreversible electroporation in unresectable perihilar cholangiocarcinoma: a systematic review and meta-analysis.
    Scrofani AR; Valvano M; Lancellotta V; Pezzulla D; Vinci A; Cornacchione P; Bonome P; Tagliaferri L; Iezzi R
    Br J Radiol; 2024 Aug; 97(1160):1413-1422. PubMed ID: 38775716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.